`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________________
`
`ROXANE LABORATORIES, INC.
`Petitioner
`
`v.
`
`NOVARTIS AG
`Patent Owner
`_______________________
`Case IPR2016-011021
`U.S. Patent No. 5,665,772
`_______________________
`
`Before LORA M. GREEN, CHRISTOPHER L. CRUMBLEY, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`PETITIONERS’ UPDATED MANDATORY NOTICE PURSUANT TO
`37 C.F.R. §42.8(b)(1)
`
`
`1 A Motion for Joinder with IPR2016-00084 is pending.
`
`
`
`Case IPR2016-01102
`U.S. Patent No. 5,665,772
`
`As set forth in the mandatory notice of related matters at page 9 of the
`
`Petition of Roxane, Laboratories, Inc. (“Roxane”) in IPR2016-01102 filed on May
`
`26, 2016, Roxane is aware of, inter alia, the following related proceeding Novartis
`
`v. Roxane, C.A. No. 14-1196-RGA. The subject of this proceeding includes an
`
`abbreviated new drug application (“ANDA”) which was submitted by Roxane.
`
`Roxane has transferred ownership of the ANDA to West-Ward
`
`Pharmaceuticals International Limited, having an address at 1 New Burlington
`
`Place, London, W1S 2JD, United Kingdom, a subsidiary of Hikma
`
`Pharmaceuticals, PLC. Accordingly, pursuant to 37 C.F.R. § 42.8(b)(1) Roxane, in
`
`an abundance of caution, identifies West-Ward Pharmaceuticals International
`
`Limited as an additional entity that is a real-party-in-interest who, going forward,
`
`may have control over this proceeding.
`
`
`
`Respectfully submitted,
`
`Dated: January 11, 2017
`
`
`By: /Marta E. Delsignore/
`Marta E. Delsignore (Reg. No. 32,689)
`Counsel for Petitioner Roxane
`Laboratories, Inc.
`
`1
`
`
`
`Case IPR2016-01102
`U.S. Patent No. 5,665,772
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), I certify that on this 11th day of January,
`
`2017, a true and correct copy of the foregoing PETITIONERS’ UPDATED
`
`MANDATORY NOTICE PURSUANT TO 37 C.F.R. §42.8(b)(1) was served by
`
`electronic mail on Patent Owner’s lead and backup counsel at the following email
`
`address:
`
`
`
`
`
`
`
`
`
`
`
`
`
`Nicholas N. Kallas (Reg. No. 31,530)
`Raymond R. Mandra (Reg. No. 34,382)
`Peter J. Waibel (Reg. No. 43,228)
`Christina Schwarz (pro hac vice)
`Charlotte Jacobsen (pro hac vice)
`Susanne L. Flanders (pro hac vice)
`Jared L. Stringham (pro hac vice)
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`ZortressAfinitorIPR@fchs.com
`
`By: /Marta E. Delsignore/
`
`Marta E. Delsignore (Reg. No. 32,689)
`GOODWIN PROCTER LLP
`620 Eighth Avenue
`New York, NY 10018
`212-813-8822
`mdelsignore@goodwinprocter.com
`
`Counsel for Petitioner
`Roxane Laboratories, Inc.